Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.

Xu J, Morinaga H, Oh D, Li P, Chen A, Talukdar S, Mamane Y, Mancini JA, Nawrocki AR, Lazarowski E, Olefsky JM, Kim JJ.

J Immunol. 2012 Aug 15;189(4):1992-9. doi: 10.4049/jimmunol.1103207. Epub 2012 Jul 9. Erratum in: J Immunol. 2013 Feb 1;190(3):1380. Mamane, Yaël [added]; Mancini, Joseph A [added]; Nawrocki, Andrea R [added].

2.

Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y(14).

Robichaud J, Fournier JF, Gagné S, Gauthier JY, Hamel M, Han Y, Hénault M, Kargman S, Levesque JF, Mamane Y, Mancini J, Morin N, Mulrooney E, Wu J, Black WC.

Bioorg Med Chem Lett. 2011 Jul 15;21(14):4366-8. doi: 10.1016/j.bmcl.2010.12.113. Epub 2010 Dec 28.

PMID:
21689930
3.

Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists.

Guay D, Beaulieu C, Belley M, Crane SN, DeLuca J, Gareau Y, Hamel M, Henault M, Hyjazie H, Kargman S, Chan CC, Xu L, Gordon R, Li L, Mamane Y, Morin N, Mancini J, Thérien M, Tranmer G, Truong VL, Wang Z, Black WC.

Bioorg Med Chem Lett. 2011 May 15;21(10):2832-5. doi: 10.1016/j.bmcl.2011.03.084. Epub 2011 Mar 30.

PMID:
21507642
4.

The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.

Gauthier JY, Belley M, Deschênes D, Fournier JF, Gagné S, Gareau Y, Hamel M, Hénault M, Hyjazie H, Kargman S, Lavallée G, Levesque JF, Li L, Mamane Y, Mancini J, Morin N, Mulrooney E, Robichaud J, Thérien M, Tranmer G, Wang Z, Wu J, Black WC.

Bioorg Med Chem Lett. 2011 May 15;21(10):2836-9. doi: 10.1016/j.bmcl.2011.03.081. Epub 2011 Mar 31.

PMID:
21507640
5.

p53-dependent translational control of senescence and transformation via 4E-BPs.

Petroulakis E, Parsyan A, Dowling RJ, LeBacquer O, Martineau Y, Bidinosti M, Larsson O, Alain T, Rong L, Mamane Y, Paquet M, Furic L, Topisirovic I, Shahbazian D, Livingstone M, Costa-Mattioli M, Teodoro JG, Sonenberg N.

Cancer Cell. 2009 Nov 6;16(5):439-46. doi: 10.1016/j.ccr.2009.09.025.

6.

The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.

Mamane Y, Chung Chan C, Lavallee G, Morin N, Xu LJ, Huang J, Gordon R, Thomas W, Lamb J, Schadt EE, Kennedy BP, Mancini JA.

Diabetes. 2009 Sep;58(9):2006-17. doi: 10.2337/db09-0323. Epub 2009 Jul 6.

7.

Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target.

Bier A, Oviedo-Landaverde I, Zhao J, Mamane Y, Kandouz M, Batist G.

Mol Cancer Ther. 2009 Apr;8(4):786-93. doi: 10.1158/1535-7163.MCT-08-0930.

8.

Characterisation of gaseous and particulate atmospheric pollutants in the East Mediterranean by diffusion denuder sampling lines.

Perrino C, Catrambone M, Esposito G, Lahav D, Mamane Y.

Environ Monit Assess. 2009 May;152(1-4):231-44. doi: 10.1007/s10661-008-0311-9. Epub 2008 Jun 6.

PMID:
18535917
9.

mTOR signaling: implications for cancer and anticancer therapy.

Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D, Sonenberg N.

Br J Cancer. 2007;96 Suppl:R11-5.

PMID:
17393579
10.

Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation.

Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK, Sonenberg N.

PLoS One. 2007 Feb 21;2(2):e242.

11.

mTOR, translation initiation and cancer.

Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N.

Oncogene. 2006 Oct 16;25(48):6416-22. Review.

PMID:
17041626
12.

[When translation arises from its TORpor].

Le Bacquer O, Martineau Y, Mamane Y.

Med Sci (Paris). 2006 May;22(5):514-8. Review. French.

13.

mTOR signaling: implications for cancer and anticancer therapy.

Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D, Sonenberg N.

Br J Cancer. 2006 Jan 30;94(2):195-9. Review.

14.

Repression of DNA repair mechanisms in IRF-4-expressing and HTLV-I-infected T lymphocytes.

Mamane Y, Loignon M, Palmer J, Hernandez E, Césaire R, Alaoui-Jamali M, Hiscott J.

J Interferon Cytokine Res. 2005 Jan;25(1):43-51.

PMID:
15684621
15.

eIF4E--from translation to transformation.

Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N.

Oncogene. 2004 Apr 19;23(18):3172-9.

PMID:
15094766
16.

Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.

Arguello M, Sgarbanti M, Hernandez E, Mamane Y, Sharma S, Servant M, Lin R, Hiscott J.

Oncogene. 2003 Feb 20;22(7):964-73.

PMID:
12592383
17.

Repression of IRF-4 target genes in human T cell leukemia virus-1 infection.

Mamane Y, Grandvaux N, Hernandez E, Sharma S, Innocente SA, Lee JM, Azimi N, Lin R, Hiscott J.

Oncogene. 2002 Oct 3;21(44):6751-65.

18.

Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells.

Sharma S, Grandvaux N, Mamane Y, Genin P, Azimi N, Waldmann T, Hiscott J.

J Immunol. 2002 Sep 15;169(6):3120-30.

19.
20.

IRF-4 activities in HTLV-I-induced T cell leukemogenesis.

Mamane Y, Sharma S, Grandvaux N, Hernandez E, Hiscott J.

J Interferon Cytokine Res. 2002 Jan;22(1):135-43. Review.

PMID:
11846984
21.

HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators.

Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, Harrington WJ Jr, Barber GN, Hiscott J.

Oncogene. 2001 Feb 15;20(7):800-11.

22.

Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes.

Sharma S, Mamane Y, Grandvaux N, Bartlett J, Petropoulos L, Lin R, Hiscott J.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1613-22.

PMID:
11080800
24.

Multiple regulatory domains control IRF-7 activity in response to virus infection.

Lin R, Mamane Y, Hiscott J.

J Biol Chem. 2000 Nov 3;275(44):34320-7.

25.

Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52.

Mamane Y, Sharma S, Petropoulos L, Lin R, Hiscott J.

Immunity. 2000 Feb;12(2):129-40.

26.

Interferon regulatory factors: the next generation.

Mamane Y, Heylbroeck C, Génin P, Algarté M, Servant MJ, LePage C, DeLuca C, Kwon H, Lin R, Hiscott J.

Gene. 1999 Sep 3;237(1):1-14. Review.

PMID:
10524230
27.

Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells.

Génin P, Mamane Y, Kwon H, LePage C, Wainberg MA, Hiscott J.

Virology. 1999 Sep 1;261(2):205-15.

29.

Triggering the interferon response: the role of IRF-3 transcription factor.

Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, Mamane Y, Algarte M, Lin R.

J Interferon Cytokine Res. 1999 Jan;19(1):1-13. Review.

PMID:
10048763
30.

A linker region of the yeast zinc cluster protein leu3p specifies binding to everted repeat DNA.

Mamane Y, Hellauer K, Rochon MH, Turcotte B.

J Biol Chem. 1998 Jul 17;273(29):18556-61.

31.

The effect of sampling line on the measurement results of sulfur dioxide a case study.

Mamane Y, Donagi AE.

J Air Pollut Control Assoc. 1976 Oct;26(10):991-2. No abstract available.

PMID:
977854

Supplemental Content

Loading ...
Support Center